Resveratrol and its higher hydroxylated analogs have been reported to possess a variety of
biological properties including
antioxidant as well as prooxidant effects. The
antioxidant properties are assumed to enable these compounds to protect cells from oxidative damage, however prooxidant activity are held likely to be responsible for their cytotoxic or pro-apoptotic effects. In present study the effects of
resveratrol (Res) and its three derivatives:
3,3',4,4'-tetrahydroxy-trans-stilbene (M6), 3,4,4',5-tetrahydroxy-trans-stilbene (M8) and
3,3',4,4',5,5'-hexahydroxy-trans-stilbene (M12) were investigated on
T cell leukemia Jurkat cells. The tested compounds have cytotoxic activity against
cancer cells and IC50 values obtained in the
Alamar blue assay were: 58.4 μM, 48.1 μM, 33.4 μM for and 13.8 μM for Res, M6, M8, M12, respectively. Furthermore, we also observed an increased activity of
caspase 3 and 9, with significantly higher values in cells incubated with M8 and M12 than Res and M6. Cell death was accompanied by loss of mitochondrial potential, oxidative stress, decrease of
glutathione level as well as loss of both
mRNA expression and activity of
superoxide dismutase (MnSOD). Cytotoxic activity may be connected with the formation of short-living prooxidative metabolites as compounds M8 and M12 were very instable in incubation medium. In conclusion, we elucidated the mechanisms responsible for cytotoxicity of hydroxylated
resveratrol analogs in
leukemia cells which may also apply to other
polyphenols.